• Cue Biopharma held a special shareholder meeting on June 1, 2026.
• Shareholders authorized share issuance tied to the exercise of certain warrants issued in May 2026 for a licensing transaction and related private placement.
• Investors adopted the 2026 Stock Incentive Plan, previously approved by the board subject to shareholder approval.
• Shareholders also backed a potential adjournment to solicit more proxies if needed, though it was not required.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cue Biopharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-255479), on June 03, 2026, and is solely responsible for the information contained therein.